ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00710580
Recruitment Status : Completed
First Posted : July 4, 2008
Last Update Posted : January 18, 2013
Sponsor:
Collaborator:
Paragon Biomedical
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : April 2009
  Certification/Extension First Submitted : August 23, 2011